INDO US BIOTECH
Back to Income Statement
|
INDO US BIOTECH Last 5 Year Revenue History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹104 Cr | ₹73 Cr | ₹62 Cr | ₹50 Cr | ₹40 Cr |
What is the latest Revenue of INDO US BIOTECH ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹104 Cr |
| Mar2024 | ₹73 Cr |
| Mar2023 | ₹62 Cr |
| Mar2022 | ₹50 Cr |
| Mar2021 | ₹40 Cr |
How is Revenue of INDO US BIOTECH Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹104 Cr | 42.56 | |
| Mar2024 | ₹73 Cr | 17.96 | |
| Mar2023 | ₹62 Cr | 23.36 | |
| Mar2022 | ₹50 Cr | 24.86 | |
| Mar2021 | ₹40 Cr | - | |
Compare Revenue of peers of INDO US BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDO US BIOTECH | ₹259.1 Cr | -0.8% | -0.3% | -48.8% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹12,770.3 Cr | -5.4% | -4.2% | -31% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹5,503.0 Cr | 7.1% | 1.1% | 15.6% | Stock Analytics | |
| VENKYS (INDIA) | ₹1,912.2 Cr | -0.2% | -7.4% | -23.1% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹1,229.5 Cr | -4.1% | -3.1% | -27.1% | Stock Analytics | |
| MANGALAM GLOBAL ENTERPRISE | ₹455.1 Cr | -0.7% | -18.5% | 15.7% | Stock Analytics | |
INDO US BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDO US BIOTECH | -0.8% |
-0.3% |
-48.8% |
| SENSEX | 1.6% |
2.7% |
6.3% |
You may also like the below Video Courses